Eczema
Information
- Disease name
- Eczema
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05913791 | Active, not recruiting | N/A | Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema | March 6, 2023 | January 2025 |
| NCT06424691 | Active, not recruiting | N/A | Infant Restore: Efficacy of Microbiome Analysis and Education | May 4, 2023 | April 14, 2025 |
| NCT01906853 | Active, not recruiting | Phase 3 | Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction | July 2013 | June 30, 2024 |
| NCT03981926 | Active, not recruiting | N/A | Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis | August 27, 2019 | December 1, 2023 |
| NCT00798226 | Active, not recruiting | Phase 1 | Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood | November 26, 2008 | July 2027 |
| NCT03667651 | Active, not recruiting | Phase 3 | The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants | March 6, 2018 | May 31, 2027 |
| NCT03832010 | Active, not recruiting | Phase 4 | Steroid-reducing Effects of Crisaborole | December 17, 2019 | December 2024 |
| NCT03409367 | Active, not recruiting | N/A | A Community-based Assessment of Skin Care, Allergies, and Eczema | July 3, 2018 | February 28, 2025 |
| NCT00663364 | Completed | N/A | Care of the Dry Skin With Physiogel AI Lotion® (W0156) | April 2008 | November 2009 |
| NCT00710489 | Completed | Potential Research Study Participant Registry | May 2008 | September 5, 2018 | |
| NCT00713089 | Completed | Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development | March 2006 | November 2009 | |
| NCT00817063 | Completed | Phase 3 | Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema | January 8, 2009 | April 26, 2012 |
| NCT00894816 | Completed | N/A | Probiotics in Prevention of Allergies, Obesity and Caries | August 2000 | November 2020 |
| NCT01020994 | Completed | Phase 2 | Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema | November 2009 | June 2010 |
| NCT01132651 | Completed | N/A | Cooling Pillow for Atopic Dermatitis | May 2010 | December 2010 |
| NCT05770271 | Completed | N/A | The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis | January 29, 2023 | January 20, 2024 |
| NCT01143012 | Completed | N/A | Group Eczema Education Visits:Impact on Patient and Family Quality of Life | May 2010 | April 13, 2014 |
| NCT01149759 | Completed | N/A | Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy | June 2010 | December 2014 |
| NCT01202149 | Completed | Phase 4 | Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis | March 2010 | November 2010 |
| NCT00365469 | Completed | Phase 2 | Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 Years | May 2006 | September 2011 |
| NCT04021862 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis | October 16, 2019 | November 19, 2020 |
| NCT00375713 | Completed | Phase 3 | Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema | October 2005 | May 2006 |
| NCT00438646 | Completed | Oral Bacteria and Allergic Disease in Children | February 2007 | ||
| NCT03871998 | Completed | N/A | Short-term Topical Application to Prevent Atopic Dermatitis | April 16, 2019 | November 30, 2021 |
| NCT03873142 | Completed | N/A | The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Children With Eczema | October 19, 2018 | August 22, 2019 |
| NCT00459576 | Completed | Risk of Asthma in Infants With Atopic Dermatitis | May 2005 | December 2012 | |
| NCT00519675 | Completed | Phase 3 | Alitretinoin in the Treatment of Chronic Hand Eczema | May 2007 | |
| NCT03619161 | Completed | N/A | Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema | June 21, 2018 | December 18, 2019 |
| NCT03627767 | Completed | Phase 3 | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects | June 11, 2018 | October 7, 2020 |
| NCT03720470 | Completed | Phase 3 | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy | October 29, 2018 | March 6, 2020 |
| NCT03735459 | Completed | N/A | Eczema Reminder and Accountability Program | November 13, 2018 | July 1, 2019 |
| NCT03738163 | Completed | N/A | A Clinical Investigation With Epaderm® Cream | April 1, 2019 | June 17, 2020 |
| NCT03775434 | Completed | Phase 1 | A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis | December 7, 2018 | June 10, 2019 |
| NCT01254240 | Completed | Phase 2 | Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases | December 2010 | December 2015 |
| NCT01257061 | Completed | Phase 3 | Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment | September 6, 2012 | August 2, 2013 |
| NCT01291940 | Completed | N/A | The Effects of Emollient Therapy on the Skin Barrier | January 2011 | December 2014 |
| NCT01359787 | Completed | Phase 2 | Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD) | May 2011 | September 2011 |
| NCT01366846 | Completed | Phase 2 | Persistence of Oral Tolerance to Peanut | May 2011 | May 2015 |
| NCT01407510 | Completed | Phase 2 | HPA Axis Study in Japanese Adults | May 9, 2011 | April 15, 2012 |
| NCT01408511 | Completed | Phase 2 | HPA Axis Study in Adults | July 19, 2011 | December 21, 2011 |
| NCT01420705 | Completed | Bacille Calmette-Guérin (BCG) Vaccine and Atopy | October 2011 | December 2011 | |
| NCT01429701 | Completed | Phase 3 | Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous | May 2012 | August 2012 |
| NCT05607511 | Completed | N/A | GB-EZ-SIM03 Probiotics Study for Childhood Eczema | April 1, 2022 | February 5, 2024 |
| NCT05583019 | Completed | Atopic Dermatitis With Accelerometry and Polysomnography (ADAP) | October 27, 2022 | May 11, 2023 | |
| NCT01567995 | Completed | Phase 3 | Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety | February 28, 2008 | February 10, 2009 |
| NCT00318695 | Completed | Phase 2 | Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses | May 2004 | January 2009 |
| NCT01714245 | Completed | A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients | November 2012 | December 2013 | |
| NCT05461456 | Completed | Phase 1 | Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% | April 1, 2022 | October 16, 2022 |
| NCT00329784 | Completed | Phase 2 | Promoting Tolerance to Peanut in High-Risk Children | December 2006 | May 2014 |
| NCT05149313 | Completed | Phase 3 | A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine | December 23, 2021 | May 7, 2024 |
| NCT01899287 | Completed | N/A | A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema | July 2012 | January 2014 |
| NCT01916980 | Completed | Phase 3 | Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202) | August 27, 2013 | March 22, 2014 |
| NCT05131477 | Completed | Phase 2 | Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study | December 13, 2021 | February 21, 2024 |
| NCT02002871 | Completed | N/A | Blue Light for Treating Eczema | October 2013 | March 2014 |
| NCT02075632 | Completed | Phase 2 | Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream | September 2006 | November 2006 |
| NCT02115399 | Completed | ADRN Barrier/Immunoprofiling Exploratory Pilot Study | April 2014 | June 2015 | |
| NCT02120833 | Completed | Phase 3 | A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin | March 2014 | November 2014 |
| NCT04986384 | Completed | N/A | Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema | January 24, 2019 | April 7, 2021 |
| NCT02251340 | Completed | N/A | Randomized Controlled Trial of an Eczema Care Plan | June 2015 | September 2016 |
| NCT00076375 | Completed | Phase 2 | Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema) | November 2003 | April 2004 |
| NCT02379507 | Completed | Phase 1 | DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study | January 2014 | June 2014 |
| NCT04800315 | Completed | Phase 2 | A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis | May 14, 2021 | November 9, 2022 |
| NCT02457000 | Completed | Sleep, Circadian Rhythm & Skin Health | March 2015 | August 2020 | |
| NCT04760314 | Completed | Phase 3 | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis | March 10, 2021 | February 1, 2023 |
| NCT04680520 | Completed | N/A | Barrier Enhancement for Eczema Prevention | November 1, 2014 | January 1, 2022 |
| NCT04510961 | Completed | N/A | Paraffin Bath Therapy for Chronic Hand Eczema | January 10, 2019 | January 25, 2020 |
| NCT02620293 | Completed | Phase 1 | A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin | April 2016 | April 2016 |
| NCT04471896 | Completed | N/A | Joovvin' for Your Skin Health Study | August 1, 2020 | February 1, 2021 |
| NCT02732314 | Completed | Phase 4 | Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis | March 2016 | June 2016 |
| NCT02871479 | Completed | Phase 2 | A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis | April 21, 2017 | August 31, 2018 |
| NCT02916888 | Completed | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists | September 2016 | December 2017 | |
| NCT03089229 | Completed | Phase 1/Phase 2 | A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis | March 26, 2017 | July 31, 2017 |
| NCT04404075 | Completed | Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use | April 25, 2022 | May 12, 2023 | |
| NCT03134352 | Completed | Phase 2 | Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema | April 26, 2017 | September 10, 2018 |
| NCT03160248 | Completed | Phase 2 | An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema | July 5, 2017 | September 15, 2021 |
| NCT04358224 | Completed | Phase 4 | The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment | September 1, 2020 | November 18, 2022 |
| NCT03293030 | Completed | Phase 4 | Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis | October 22, 2018 | February 23, 2023 |
| NCT04023084 | Completed | Phase 4 | Response of Children With Atopic Dermatitis (Eczema) to Eucrisa | October 3, 2019 | February 11, 2022 |
| NCT03406325 | Completed | Mast Cell Activation Test in Allergic Disease | February 1, 2018 | December 1, 2019 | |
| NCT03461848 | Completed | N/A | CYPHP Evelina London Evaluation | April 9, 2018 | March 31, 2022 |
| NCT03563066 | Completed | Phase 2 | Effect of Benralizumab in Atopic Dermatitis | September 4, 2018 | September 28, 2021 |
| NCT05747378 | Not yet recruiting | Finding Patterns In Clinical Trial Experiences of Patients With Eczema | March 2024 | March 2026 | |
| NCT05873933 | Not yet recruiting | N/A | An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes | July 1, 2024 | November 1, 2024 |
| NCT06464133 | Not yet recruiting | Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis | July 15, 2024 | December 31, 2027 | |
| NCT05473325 | Not yet recruiting | Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) | January 1, 2023 | June 22, 2025 | |
| NCT06353087 | Not yet recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) | April 1, 2024 | November 15, 2025 | |
| NCT03664271 | Not yet recruiting | N/A | Educational Eczema Video Intervention | January 2025 | December 2026 |
| NCT04809571 | Recruiting | N/A | Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring | February 22, 2021 | January 31, 2024 |
| NCT00177268 | Recruiting | Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research | October 2004 | January 2032 | |
| NCT00605878 | Recruiting | Studies of Skin Microbes in Healthy People and in People With Skin Conditions | January 22, 2008 | ||
| NCT01631617 | Recruiting | Phase 2 | Effects of Treatments on Atopic Dermatitis | September 18, 2012 | January 1, 2025 |
| NCT01782703 | Recruiting | Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis | January 2013 | December 2025 | |
| NCT03742414 | Recruiting | Phase 2 | Seal, Stopping Eczema and Allergy Study | June 30, 2021 | June 30, 2027 |
| NCT03800004 | Recruiting | Bone Health in Patients With Atopic Dermatitis | July 30, 2018 | December 2024 | |
| NCT03840928 | Recruiting | PatientSpot Formerly Known as ArthritisPower | April 1, 2015 | March 1, 2025 | |
| NCT04818138 | Recruiting | N/A | BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort | September 27, 2021 | June 2025 |
| NCT04919265 | Recruiting | Mother-Infant Cohort Study in Malaysia and China | June 3, 2022 | May 2025 | |
| NCT04919330 | Recruiting | N/A | Acceptance and Commitment Therapy-based Eczema Management Programme | July 3, 2021 | February 28, 2024 |
| NCT05330637 | Recruiting | Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China. | March 3, 2022 | April 30, 2025 | |
| NCT05559359 | Recruiting | Phase 3 | A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis | October 18, 2022 | June 15, 2025 |
| NCT05689151 | Recruiting | A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis. | March 9, 2023 | May 31, 2027 | |
| NCT05735483 | Recruiting | Phase 3 | A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis | March 9, 2023 | June 26, 2026 |
| NCT05758532 | Recruiting | Phase 4 | Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children | March 17, 2023 | December 2026 |
| NCT05928169 | Recruiting | Determinants of Chronic Inflammatory Skin Disease Trajectories | May 1, 2023 | December 31, 2032 | |
| NCT05938478 | Recruiting | Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT | December 8, 2022 | September 30, 2035 | |
| NCT05990725 | Recruiting | Phase 3 | Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis | November 20, 2023 | May 1, 2025 |
| NCT06072287 | Recruiting | The Living With a Long-Term Condition Study | June 28, 2023 | January 10, 2024 | |
| NCT06096857 | Recruiting | Phase 2 | Cardamom and Topical Roseomonas in Atopic Dermatitis | July 1, 2024 | January 1, 2026 |
| NCT06124781 | Recruiting | N/A | Molecular Diagnosis of Allergic Contact Dermatitis (SMECA). | June 20, 2023 | December 20, 2024 |
| NCT06155513 | Recruiting | N/A | Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema | December 20, 2023 | May 1, 2025 |
| NCT06268847 | Recruiting | N/A | Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms | January 9, 2024 | June 18, 2024 |
| NCT06436183 | Recruiting | Phase 2 | A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis | May 1, 2024 | June 2025 |
| NCT02404493 | Terminated | N/A | Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin | March 2015 | March 2016 |
| NCT00924508 | Terminated | N/A | Hydrogel Patch for the Treatment of Eczema | July 2008 | July 2012 |
| NCT01826630 | Terminated | N/A | A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema | July 2013 | October 2014 |
| NCT01122914 | Terminated | Phase 1 | A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis | April 14, 2010 | April 7, 2015 |
| NCT01577628 | Terminated | N/A | Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis | June 2012 | February 2013 |
| NCT05732454 | Terminated | Phase 2/Phase 3 | A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection | January 18, 2023 | April 29, 2024 |
| NCT00143819 | Terminated | Phase 2 | Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis | September 2005 | February 2010 |
| NCT04001855 | Terminated | N/A | Evaluating the Effect of Bathing Additives in Atopic Dermatitis | July 1, 2019 | May 31, 2020 |
| NCT03775590 | Terminated | N/A | The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis | February 21, 2019 | September 15, 2019 |
| NCT02713035 | Terminated | N/A | Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients | March 2016 | July 2017 |
| NCT02286700 | Unknown status | Phase 3 | Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis | November 2014 | March 2015 |
| NCT05439577 | Unknown status | A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema | September 23, 2021 | November 30, 2022 | |
| NCT01779180 | Unknown status | Vitamin A Supplementation at Birth and Atopy in Childhood | January 2013 | February 2014 | |
| NCT02536560 | Unknown status | Intestinal Microbiota Composition After Antibiotic Treatment in Early Life | January 2012 | October 2016 | |
| NCT01012453 | Unknown status | N/A | A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema | October 2009 | |
| NCT01498965 | Unknown status | The Cork BASELINE Birth Cohort Study | August 2008 | January 2017 | |
| NCT01473823 | Unknown status | N/A | Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in Childhood | January 2012 | December 2020 |
| NCT00465699 | Unknown status | N/A | Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis | April 2007 | April 2007 |
| NCT04520308 | Unknown status | Phase 4 | An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis | September 1, 2020 | March 31, 2021 |
| NCT04617977 | Unknown status | N/A | Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From Eczema | August 23, 2021 | December 31, 2023 |
| NCT03823794 | Unknown status | Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK) | February 1, 2019 | June 1, 2020 | |
| NCT02533635 | Unknown status | Phase 1/Phase 2 | Ganoderma Tea on Eczema Patient | August 2015 | December 2016 |
| NCT04154839 | Unknown status | Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong | July 12, 2019 | June 30, 2022 | |
| NCT04214548 | Unknown status | A Pilot Study to Explore the Role of Gut Flora in Eczema | March 2, 2020 | July 2023 | |
| NCT03192748 | Unknown status | A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World | June 19, 2017 | June 30, 2019 | |
| NCT01142999 | Unknown status | N/A | Feasibility Study of Barrier Enhancement for Eczema Prevention | May 2010 | September 2012 |
| NCT05265234 | Unknown status | Phase 4 | Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. | March 1, 2022 | March 1, 2024 |
| NCT05413395 | Unknown status | N/A | Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO) | June 17, 2022 | March 1, 2024 |
| NCT02517957 | Unknown status | Phase 2 | Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research | August 2015 | |
| NCT03340155 | Unknown status | N/A | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases | October 30, 2017 | October 2022 |
| NCT04133506 | Unknown status | PGE2/IL-22 Pathway in Various Forms of Eczema | November 2019 | February 2022 | |
| NCT04019769 | Withdrawn | Early Phase 1 | Glutamine Supplementation in People With Immune Dysregulation | March 12, 2020 | January 1, 2021 |
| NCT01230190 | Withdrawn | Phase 3 | Management of Eczema by Specific Probiotic Strains | March 2011 | July 2011 |
| NCT01960764 | Withdrawn | Phase 1 | Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival | June 2016 | December 2022 |
| NCT03089476 | Withdrawn | N/A | Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy | September 30, 2017 | July 30, 2018 |
| NCT04965233 | Withdrawn | Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant Phenotypes | November 30, 2020 | December 31, 2021 | |
| NCT02144142 | Withdrawn | Phase 2 | Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients | July 2015 | July 2022 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0001481
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000964
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004485